Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -196,273 | -199,590 | -178,407 | -128,984 | -109,577 |
| Depreciation Amortization | 10,462 | 6,785 | 2,184 | 1,900 | 1,916 |
| Accounts receivable | -5,019 | -7,862 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,465 | -3,301 | -1,380 | 909 | 945 |
| Other Working Capital | 1,170 | -13,308 | -169 | 32,962 | 987 |
| Other Operating Activity | 25,961 | 26,454 | 18,655 | 19,496 | 21,338 |
| Operating Cash Flow | $-160,234 | $-190,822 | $-159,117 | $-73,717 | $-84,391 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -145 | -206 | -2,363 | -62 | -70 |
| Purchase Of Investment | -274,577 | -178,489 | -242,811 | -98,374 | -134,700 |
| Sale Of Investment | 221,037 | 257,145 | 137,510 | 115,544 | 159,365 |
| Investing Cash Flow | $-53,685 | $78,450 | $-107,664 | $17,108 | $24,595 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 166,885 | N/A | N/A |
| Common Stock Issued | 172,083 | 50,696 | 149,224 | 75,743 | 51,203 |
| Other Financing Activity | 0 | 73,609 | 0 | 0 | -39 |
| Financing Cash Flow | $172,083 | $124,305 | $316,109 | $75,743 | $51,164 |
| Exchange Rate Effect | 268 | 19 | -78 | 211 | -66 |
| Beginning Cash Position | 130,689 | 118,737 | 69,487 | 50,142 | 58,840 |
| End Cash Position | 89,121 | 130,689 | 118,737 | 69,487 | 50,142 |
| Net Cash Flow | $-41,568 | $11,952 | $49,250 | $19,345 | $-8,698 |
| Free Cash Flow | |||||
| Operating Cash Flow | -160,234 | -190,822 | -159,117 | -73,717 | -84,391 |
| Capital Expenditure | -145 | -206 | -2,363 | -62 | -70 |
| Free Cash Flow | -160,379 | -191,028 | -161,480 | -73,779 | -84,461 |